Literature DB >> 25065622

Galectin-9-CD44 interaction enhances stability and function of adaptive regulatory T cells.

Chuan Wu1, Theresa Thalhamer1, Rafael F Franca1, Sheng Xiao1, Chao Wang1, Chie Hotta1, Chen Zhu1, Mitsuomi Hirashima2, Ana C Anderson1, Vijay K Kuchroo3.   

Abstract

The β-galactoside-binding protein galectin-9 is critical in regulating the immune response, but the mechanism by which it functions remains unclear. We have demonstrated that galectin-9 is highly expressed by induced regulatory T cells (iTreg) and was crucial for the generation and function of iTreg cells, but not natural regulatory T (nTreg) cells. Galectin-9 expression within iTreg cells was driven by the transcription factor Smad3, forming a feed-forward loop, which further promoted Foxp3 expression. Galectin-9 increased iTreg cell stability and function by directly binding to its receptor CD44, which formed a complex with transforming growth factor-β (TGF-β) receptor I (TGF-βRI), and activated Smad3. Galectin-9 signaling was further found to regulate iTreg cell induction by dominantly acting through the CNS1 region of the Foxp3 locus. Our data suggest that exogenous galectin-9, in addition to being an effector molecule for Treg cells, acts synergistically with TGF-β to enforce iTreg cell differentiation and maintenance.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25065622      PMCID: PMC4219323          DOI: 10.1016/j.immuni.2014.06.011

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  69 in total

1.  Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells.

Authors:  Estelle Bettelli; Yijun Carrier; Wenda Gao; Thomas Korn; Terry B Strom; Mohamed Oukka; Howard L Weiner; Vijay K Kuchroo
Journal:  Nature       Date:  2006-04-30       Impact factor: 49.962

2.  T cell receptor stimulation-induced epigenetic changes and Foxp3 expression are independent and complementary events required for Treg cell development.

Authors:  Naganari Ohkura; Masahide Hamaguchi; Hiromasa Morikawa; Kyoko Sugimura; Atsushi Tanaka; Yoshinaga Ito; Motonao Osaki; Yoshiaki Tanaka; Riu Yamashita; Naoko Nakano; Jochen Huehn; Hans Joerg Fehling; Tim Sparwasser; Kenta Nakai; Shimon Sakaguchi
Journal:  Immunity       Date:  2012-11-01       Impact factor: 31.745

3.  Smad-dependent cooperative regulation of interleukin 2 receptor alpha chain gene expression by T cell receptor and transforming growth factor-beta.

Authors:  Hyoung-Pyo Kim; Byung-Gyu Kim; John Letterio; Warren J Leonard
Journal:  J Biol Chem       Date:  2005-08-08       Impact factor: 5.157

4.  The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity.

Authors:  Chen Zhu; Ana C Anderson; Anna Schubart; Huabao Xiong; Jaime Imitola; Samia J Khoury; Xin Xiao Zheng; Terry B Strom; Vijay K Kuchroo
Journal:  Nat Immunol       Date:  2005-11-13       Impact factor: 25.606

5.  A function for interleukin 2 in Foxp3-expressing regulatory T cells.

Authors:  Jason D Fontenot; Jeffrey P Rasmussen; Marc A Gavin; Alexander Y Rudensky
Journal:  Nat Immunol       Date:  2005-10-16       Impact factor: 25.606

6.  Cell surface galectin-9 expressing Th cells regulate Th17 and Foxp3+ Treg development by galectin-9 secretion.

Authors:  Souichi Oomizu; Tomohiro Arikawa; Toshiro Niki; Takeshi Kadowaki; Masaki Ueno; Nozomu Nishi; Akira Yamauchi; Toshio Hattori; Tsutomu Masaki; Mitsuomi Hirashima
Journal:  PLoS One       Date:  2012-11-07       Impact factor: 3.240

7.  Smad3 binding to the foxp3 enhancer is dispensable for the development of regulatory T cells with the exception of the gut.

Authors:  Susan M Schlenner; Benno Weigmann; Qingguo Ruan; Youhai Chen; Harald von Boehmer
Journal:  J Exp Med       Date:  2012-08-20       Impact factor: 14.307

8.  Neuropilin-1 distinguishes natural and inducible regulatory T cells among regulatory T cell subsets in vivo.

Authors:  Mahesh Yadav; Cedric Louvet; Dan Davini; James M Gardner; Marc Martinez-Llordella; Samantha Bailey-Bucktrout; Bryan A Anthony; Francis M Sverdrup; Richard Head; Daniel J Kuster; Peter Ruminski; David Weiss; David Von Schack; Jeffrey A Bluestone
Journal:  J Exp Med       Date:  2012-09-10       Impact factor: 14.307

9.  Galectin-9 and IL-21 mediate cross-regulation between Th17 and Treg cells during acute hepatitis C.

Authors:  Hassen Kared; Thomas Fabre; Nathalie Bédard; Julie Bruneau; Naglaa H Shoukry
Journal:  PLoS Pathog       Date:  2013-06-20       Impact factor: 6.823

10.  Neuropilin 1 is expressed on thymus-derived natural regulatory T cells, but not mucosa-generated induced Foxp3+ T reg cells.

Authors:  Jonathan M Weiss; Angelina M Bilate; Michael Gobert; Yi Ding; Maria A Curotto de Lafaille; Christopher N Parkhurst; Huizhong Xiong; Jayashree Dolpady; Alan B Frey; Maria Grazia Ruocco; Yi Yang; Stefan Floess; Jochen Huehn; Soyoung Oh; Ming O Li; Rachel E Niec; Alexander Y Rudensky; Michael L Dustin; Dan R Littman; Juan J Lafaille
Journal:  J Exp Med       Date:  2012-09-10       Impact factor: 14.307

View more
  106 in total

Review 1.  Towards molecular mechanisms regulating the expression of galectins in cancer cells under microenvironmental stress conditions.

Authors:  Alexander V Timoshenko
Journal:  Cell Mol Life Sci       Date:  2015-08-06       Impact factor: 9.261

2.  Acute stimulation generates Tim-3-expressing T helper type 1 CD4 T cells that persist in vivo and show enhanced effector function.

Authors:  Jacob V Gorman; John D Colgan
Journal:  Immunology       Date:  2018-02-08       Impact factor: 7.397

3.  CD206-positive myeloid cells bind galectin-9 and promote a tumor-supportive microenvironment.

Authors:  Elizabeth Ann L Enninga; Kyriakos Chatzopoulos; John T Butterfield; Shari L Sutor; Alexey A Leontovich; Wendy K Nevala; Thomas J Flotte; Svetomir N Markovic
Journal:  J Pathol       Date:  2018-06-28       Impact factor: 7.996

Review 4.  A review of the importance of immune responses in luminal B breast cancer.

Authors:  Delia J Nelson; Briony Clark; Kylie Munyard; Vincent Williams; David Groth; Jespal Gill; Henry Preston; Arlene Chan
Journal:  Oncoimmunology       Date:  2017-01-19       Impact factor: 8.110

5.  Potential effect of tumor-specific Treg-targeted antibodies in the treatment of human cancers: A bioinformatics analysis.

Authors:  Luigi Cari; Giuseppe Nocentini; Graziella Migliorati; Carlo Riccardi
Journal:  Oncoimmunology       Date:  2017-11-09       Impact factor: 8.110

Review 6.  Breaking the Glyco-Code of HIV Persistence and Immunopathogenesis.

Authors:  Florent Colomb; Leila B Giron; Irena Trbojevic-Akmacic; Gordan Lauc; Mohamed Abdel-Mohsen
Journal:  Curr HIV/AIDS Rep       Date:  2019-04       Impact factor: 5.071

Review 7.  Potential of glycosylation research in graft versus host disease after allogeneic hematopoietic stem cell transplantation.

Authors:  Ema Prenc; Drazen Pulanic; Maja Pucic-Bakovic; Marija Pezer; Lana Desnica; Radovan Vrhovac; Damir Nemet; Steven Z Pavletic
Journal:  Biochim Biophys Acta       Date:  2016-02-26

Review 8.  Galectin-9: From cell biology to complex disease dynamics.

Authors:  Sebastian John; Rashmi Mishra
Journal:  J Biosci       Date:  2016-09       Impact factor: 1.826

9.  YAP Is Essential for Treg-Mediated Suppression of Antitumor Immunity.

Authors:  Xuhao Ni; Jinhui Tao; Joseph Barbi; Qian Chen; Benjamin V Park; Zhiguang Li; Nailing Zhang; Andriana Lebid; Anjali Ramaswamy; Ping Wei; Ying Zheng; Xuehong Zhang; Xingmei Wu; Paolo Vignali; Cui-Ping Yang; Huabin Li; Drew Pardoll; Ling Lu; Duojia Pan; Fan Pan
Journal:  Cancer Discov       Date:  2018-06-15       Impact factor: 39.397

10.  Galectin-9 modulates immunity by promoting Th2/M2 differentiation and impacts survival in patients with metastatic melanoma.

Authors:  Elizabeth Ann L Enninga; Wendy K Nevala; Shernan G Holtan; Alexey A Leontovich; Svetomir N Markovic
Journal:  Melanoma Res       Date:  2016-10       Impact factor: 3.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.